Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WM

COPENHAGEN, Denmark, Sept. 14, 2023 /PRNewswire/ -- Curasight A/S ("Curasight" or the "Company" - TICKER:...

Related Keywords

Copenhagen ,Køavn ,Denmark ,Prague ,Praha ,Hlavníesto ,Czech Republic ,Aleena Azam ,Ulrich Krasilnikoff ,World Molecular Imaging Congress ,University Of Copenhagen ,Primary Gliomas ,Prognostic Value ,Targeted Radionuclide ,Molecular Imaging ,Springer Publisher ,Positron Emissions Tomography ,Radionuclide Therapy ,